COMMUNIQUÉS West-GlobeNewswire

Fagron NV: Disclosure of received notification

23/10/2018 - 18:02

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 23 October 2018 - 6:00pm (CET) Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron [...]

EUROBIO SCIENTIFIC CERTIFIED ISO 13485 V2016

23/10/2018 - 17:47

EUROBIO SCIENTIFIC CERTIFIED ISO 13485 V2016 Eurobio Scientific has successfully upgraded its quality management systems in order to continue justifying CE marking of its products beyond 2019 Paris, October 23, 2018 - 5 [...]

EUROBIO SCIENTIFIC CERTIFIE ISO 13485 V2016

23/10/2018 - 17:47

EUROBIO SCIENTIFIC CERTIFIE ISO 13485 V2016 Eurobio Scientific a fait évoluer avec succès ses systèmes de management de la qualité pour continuer à justifier du marquage CE de ses produits au-delà de 2019 Paris, le 23 [...]

Transactions in relation to share buyback program

23/10/2018 - 17:14

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

South Texas Veterans Health Care System Joins Test Validation Trial of bioAffinity’s CyPath® Lung

23/10/2018 - 17:00

SAN ANTONIO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the South Texas Veterans Health Care System (STVHCS), which is affiliated with the federal [...]

Tabula Rasa Healthcare to Announce Third Quarter 2018 Operating Results and Host Conference Call on Tuesday, November 6, 2018

23/10/2018 - 16:00

MOORESTOWN, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, will release its third quarter 2018 operating [...]

AroCell AB announces the appointment of a new CEO

23/10/2018 - 15:45

Michael Brobjer has been appointed new CEO of AroCell and will join the company December 8, 2018. Mr.Brobjer will provide AroCell with valuable expertise through his extensive experience in the pharmaceutical and [...]

Precipio Expands ICE COLD-PCR™ Menu for Breast, Colon and Endometrial Cancers

23/10/2018 - 15:15

Ultra-sensitive assays for PIK3CA exons 9 & 20 detect mutations that impact critical therapeutic decisions NEW HAVEN, Conn., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. ( NASDAQ: PRPO ), announced today that it [...]

Admera Health Expands Liquid Biopsy Offering to Include Detection of Copy Number Variation and Microsatellite Instability

23/10/2018 - 15:13

SOUTH PLAINFIELD, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- At CAP18, in Chicago, IL, Admera Health ( www.admerahealth.com ), unveiled an expansion to its next generation sequencing (NGS) based LiquidGx™ test for solid [...]

New U.S. Patent Allowance Granted to AXIM® Biotechnologies for Suppository Formulations Comprised of Cannabinoids

23/10/2018 - 15:10

NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that the United States Patent [...]

Obalon Schedules Third Quarter 2018 Financial Results Conference Call for November 2, 2018 at 8:30 a.m. Eastern Time

23/10/2018 - 15:04

SAN DIEGO, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled [...]

Medtronic Receives FDA Approval for Valiant Navion(TM) Thoracic Stent Graft System

23/10/2018 - 15:01

Next-Generation Thoracic Endovascular Repair (TEVAR) Device Expands Applicability to Broader Range of Patients DUBLIN - October 23, 2018 - Medtronic plc (NYSE:MDT) today announced it has received U.S. Food and Drug [...]

Acasti Pharma Announces Closing of C$27.6 Million Underwritten Public Offering of Common Shares Including the Exercise of the Over-Allotment Option

23/10/2018 - 15:00

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. LAVAL, Quebec, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST) (TSXV: ACST) (the “ Company ” or “ Acasti ”), a [...]

eTrueNorth Strengthens Delivery System with PDHI Partnership

23/10/2018 - 15:00

Collaboration further empowers local retail pharmacies to perform wellness screenings FORT WORTH, Texas, Oct. 23, 2018 (GLOBE NEWSWIRE) -- e TrueNorth, the premier, integrated pharmacy-based clinical-services network, [...]

Eyenovia to Present at the Ophthalmology Innovation Summit at the American Academy of Ophthalmology 2018

23/10/2018 - 15:00

NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed [...]

Lexaria Bioscience Corp. Discusses The Importance of New Subsidiaries and Intellectual Property with Uptick Newswire’s Stock Day Podcast

23/10/2018 - 15:00

PHOENIX, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Lexaria Bioscience Corp. (OTCQX: LXRP ) (CSE: LXX) (the “Company” or “Lexaria”) is a drug delivery platform innovator that has developed and out-licenses its disruptive [...]

Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2018

23/10/2018 - 15:00

SALT LAKE CITY, Oct. 23, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- In the third calendar quarter (3Q) and first nine months (9M) of 2018, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved results which conform with [...]

Village Farms Exclusive Onsite Video and Interview -- CFN Media

23/10/2018 - 15:00

SEATTLE, Oct. 23, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- FN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Insmed to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, October 30, 2018

23/10/2018 - 14:30

BRIDGEWATER, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will release [...]